OPTH and 8BN Related Headlines
Go Back- OPTIMI Health adds 1mg and 2mg psilocybin doses for clinical research
- Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research
- Optimi Health prices $15 million offering, lists on NASDAQ
- Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting
OPTH and 8BN Related Press Releases
Go Back- Optimi Health Launches Standardized Microdose Psilocybin Products for Clinical Research
- Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting
